These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10404712)

  • 1. The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression.
    Burnett FE; Scott LV; Weaver MG; Medbak SH; Dinan TG
    J Affect Disord; 1999 Jun; 53(3):263-8. PubMed ID: 10404712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls.
    Martín del Campo AF; Dowson JH; Herbert J; Paykel ES
    J Affect Disord; 2000; 57(1-3):37-47. PubMed ID: 10708814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioid tone in patients with rheumatoid arthritis.
    Kassimos D; Choy EH; Grossman AB; Chikanza IC; Panayi GS
    Br J Rheumatol; 1996 May; 35(5):436-40. PubMed ID: 8646433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV; Burnett F; Medbak S; Dinan TG
    Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report.
    Oswald LM; McCaul M; Choi L; Yang X; Wand GS
    Biol Psychiatry; 2004 Jan; 55(1):102-5. PubMed ID: 14706432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D; Altemus M; Galliven E; Hill L; Greenberg BD; Gold P
    Neuropsychopharmacology; 1996 Aug; 15(2):207-12. PubMed ID: 8840357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals.
    Krause D; Warnecke M; Schuetz CG; Soyka M; Manz KM; Proebstl L; Kamp F; Chrobok AI; Pogarell O; Koller G
    Eur Addict Res; 2018; 24(5):255-265. PubMed ID: 30423575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects.
    Wand GS; Weerts EM; Kuwabara H; Frost JJ; Xu X; McCaul ME
    Psychoneuroendocrinology; 2011 Nov; 36(10):1453-9. PubMed ID: 21549509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.